Affinity Asset Advisors »

Revolution Medicines shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Revolution Medicines (RVMD) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Revolution Medicines

Tip: Access up to 7 years of quarterly data

All positions including Revolution Medicines held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revolution Medicines by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $8.0M 100k 79.65
2025-09-30 $4.7M 100k 46.70

More positions owned by Affinity Asset Advisors

Spdr Series Trust State Street Spd Put Option (XBI)
Apogee Therapeutics (APGE)
Insmed Com Par $.01 (INSM)
Abivax Sa Sponsored Ads (ABVX)
Ishares Tr Ishares Biotech Call Option (IBB)
Ventyx Biosciences (VTYX)
Xenon Pharmaceuticals (XENE)
Praxis Precision Medicines I Com New (PRAX)
Cytokinetics Com New (CYTK)
Amgen (AMGN)
Spyre Therapeutics Com New (SYRE)
Wave Life Sciences SHS (WVE)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Select Sector Spdr Tr State Street Hea Call Option (XLV)
Roivant Sciences SHS (ROIV)

View all positions for Affinity Asset Advisors

Top funds holding Revolution Medicines

Vanguard Group
Farallon Capital Management
Henderson Group
Wellington Management Company
Baker Bros. Advisors
FMR
BlackRock
Nextech Invest
Paradigm Biocapital Advisors
Bellevue Group
Alphabet
State Street Corporation
BVF
Geode Capital Management
UBS Group

View all funds holding Revolution Medicines